James Shannon

Former Chief Medical Officer at GlaxoSmithKline Plc

James Shannon

James Shannon

Former Chief Medical Officer at GlaxoSmithKline Plc

Career Highlights

Cerimon Pharmaceuticals, Inc.

RelSci Relationships


Number of Boards






RelSci Relationships are individuals James Shannon likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director at Vestergaard Frandsen SA

Relationship likelihood: Strong

Chairman, President & Chief Executive Officer at Horizon Pharma PLC

Relationship likelihood: Strong

Chairman at Sofinnova Partners SAS

Relationship likelihood: Strong

Co-Founder at ProQR Therapeutics NV

Relationship likelihood: Strong

Co-Founder at Mpm Capital LLC

Relationship likelihood: Strong

Chief Accounting Officer & Senior Vice President at Horizon Pharma PLC

Relationship likelihood: Strong

Co-Founder at ENYO Pharma SA

Relationship likelihood: Strong

Director & Managing Partner at Deerhaven Partners

Relationship likelihood: Strong

Managing Director & Founding Partner at BAR Capital Management LLC

Relationship likelihood: Strong

Partner at CVC Advisers Ltd.

Relationship likelihood: Strong

Paths to James Shannon
Potential Connections via
Relationship Science
James Shannon
Former Chief Medical Officer at GlaxoSmithKline Plc
MD in Medicine

QUB provides education & research.

Career History
Chief Medical Officer
2012 - 2015

GlaxoSmithKline Plc is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

President & Chief Executive Officer
2008 - 2011

Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA.

Global Head of Project Management
1994 - 2008

Novartis Pharma AG develops and manufactures pharmaceuticals. It is a subsidiary of Novartis AG. The company is headquartered in Basel, Germany.

Boards & Committees
Member, Board of Directors
2017 - Current

Horizon Therapeutics Plc is a biopharmaceutical company which is engaged in the research, development and market of pharmaceutical products. The medicines intend to treat arthritis, inflammation and orphan diseases. It distributes its products under the brands such as Actimmune, Buphenyl, Duexis, Krystexxa, Migergot, Pennsaid, Ravicti, Rayos and Vimovo. The company was founded in 2008 and is headquartered in Dublin, Ireland.

Chairman, Supervisory Board
2016 - Current

Impatients N.V. operates an online platform for drug innovations. It provides physicians and patients that are excluded from clinical trials access to drugs in development via early access programs. The company was founded by Ronald Brus, SJaak Vink, Govert J. Schouten, Witt Jan, Erdem Yavuz, and René Beukema in 2012 and is headquartered in Amsterdam, the United Kingdom.

Member, Supervisory Board
2016 - Current

ProQR Therapeutics NV operates as a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by James Shannon. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of James Shannon's profile does not indicate a business or promotional relationship of any kind between RelSci and James Shannon.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/james-shannon-4196447
  • https://relationshipscience.com/person/james-shannon-4196447